Numinus Wellness (TSX:NUMI) Expands Psychedelic Clinics amid Rising Investor Interest

VANCOUVER — October 27, 2025 Leads & Copy — Numinus Wellness Inc. (TSX:NUMI) announced the opening of two new psychedelic-assisted therapy clinics in Ontario this week, marking a strategic expansion of its national footprint and driving renewed interest from retail investors.

The Vancouver-based company said the new locations in Ottawa and Hamilton will offer ketamine-assisted psychotherapy and integration services, with plans to introduce psilocybin protocols pending Health Canada approvals.

CEO Payton Nyquvest said the expansion reflects growing demand for regulated psychedelic therapies and positions Numinus as a leading operator in Canada’s emerging mental health treatment market.

“Our clinic model is scalable and designed to meet the increasing need for safe, evidence-based psychedelic care,” said Nyquvest.

Shares of Numinus rose 14 per cent this week to close at $0.28 on the TSX, with trading volume doubling compared to the previous month.

The company also reported preliminary Q3 revenue of $3.2 million, up 22 per cent year-over-year, driven by clinical services and licensing fees.

Numinus is one of several Canadian firms advancing psychedelic-assisted therapy, alongside MindMed (Nasdaq:MNMD) and Cybin Inc. (NYSE American:CYBN), as investors seek exposure to alternative mental health solutions.



×

Welcome!

CannabisReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy

By Subscribing you will receive Daily Cannabis Story Leads via email 10:30 am ET Mon-Fri.